Smoking: Clinical Trials

6 trials for Smoking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Terminated 6
Phase 22Terminated 2

Follow Smoking: new trials by email Literature Review of Smoking trials Research Report on Smoking

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mindfulness Training Plus Oxytocin Effects on Smoking Behavior
Oxytocin, Mindfulness, Saline Solution - Smoking, Smoking Cessation
Phase 2 / Phase 3TerminatedUniversity of Southern California202018-10-102024-06-14
Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Metoprolol succinate, Placebo - Pulmonary Disease, Chronic Obstructive
Phase 3TerminatedUniversity of Minnesota5322016-05-012021-01-25
Tailored Smoking Cessation Treatment for LIVE FOR LIFEĀ® Participants
varenicline (Chantix), bupropion (Zyban), nicotine patches - Cigarette Smoking, Nicotine Dependence
Phase 2 / Phase 3TerminatedDuke University192012-05-012014-12-24
Varenicline and Alcohol in Inpatient Addictions Program (IAP)
Varenicline - Alcoholism, Nicotine Dependence
Phase 3TerminatedMayo Clinic12011-01-012019-03-20
Simvastatin Therapy for Moderate and Severe COPD
simvastatin, Placebo - Pulmonary Disease, Chronic Obstructive
Phase 3TerminatedUniversity of Minnesota8852010-03-012018-01-02
Nurse Smoking Cessation of Patients With Chronic Obstructive Pulmonary Disease (COPD) With Nicotine Replacement Therapy (NRT) and Behavioral Support
nicotine sublingual tablets, low and high behavior support - Smoking, COPD
Phase 3TerminatedUniversity Hospital, Gentofte, Copenhagen3002002-02-012005-10-21

Narrower conditions

Pulmonary Disease, Chronic Obstructive (3)  ·  Smoking Cessation (2)  ·  Tobacco Use Disorder (2)  ·  Alcoholism (1)  ·  Body Weight (1)  ·  Cigarette Smoking (1)  ·  Smoking Reduction (1)

Broader conditions

Behavior (6)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Lung Diseases (3)  ·  Lung Diseases, Obstructive (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Respiratory Tract Diseases (3)  ·  Chemically-Induced Disorders (2)  ·  Health Behavior (2)  ·  Mental Disorders (2)  ·  Substance-Related Disorders (2)  ·  Alcohol-Related Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Varenicline (2)  ·  Bupropion (1)  ·  Metoprolol (1)  ·  Mindfulness (1)  ·  Oxytocin (1)  ·  Saline Solution (1)  ·  Simvastatin (1)  ·  Sugars (1)  ·  Tobacco Use Cessation Devices (1)

Sponsors

University of Minnesota (2)  ·  Duke University (1)  ·  Mayo Clinic (1)  ·  University Hospital, Gentofte, Copenhagen (1)  ·  University of Southern California (1)

Countries

United States (5)  ·  Canada (1)  ·  Denmark (1)

Top investigators

Mark Dransfield, MD (2)  ·  Dennis E Niewoehner, MD (1)  ·  Don Sin, M.D. (1)  ·  Fernando J Martinez, MD (1)  ·  Frank Sciurba, MD (1)  ·  George Washko, MD (1)  ·  Gerard J Criner, MD (1)  ·  Jed E Rose, Ph.D. (1)  ·  John Connett, PhD (1)  ·  John E Connett, PhD (1)  ·  Mark Frye, MD (1)  ·  Matthew Kirkpatrick, PhD (1)  ·  Richard Casaburi, MD, PhD (1)  ·  Richard K Albert, MD (1)

Results publications

PMID 24836125, PMID 27267111, PMID 29065885, PMID 29444682, PMID 31633896, PMID 33638931, PMID 34229290, PMID 35363600

NIH funding

U10HL074424 (1)